Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.

[1]  I. Ng,et al.  MicroRNA‐125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B 2 , 2010, Hepatology.

[2]  Derek Y. Chiang,et al.  Cancer gene discovery in hepatocellular carcinoma. , 2010, Journal of hepatology.

[3]  I. Ng,et al.  RhoGTPases and Rho‐effectors in hepatocellular carcinoma metastasis: ROCK N' Rho move it , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[4]  Ming Yao,et al.  Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA , 2010, Nature Cell Biology.

[5]  Ming Yao,et al.  MicroRNA‐30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma , 2010, Hepatology.

[6]  Ji Wan,et al.  Structure and activity of putative intronic miRNA promoters. , 2010, RNA.

[7]  J. Llovet,et al.  Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. , 2010, Seminars in liver disease.

[8]  Zhimin Zhang,et al.  MicroRNA‐224 is upregulated in HepG2 cells and involved in cellular migration and invasion , 2010, Journal of gastroenterology and hepatology.

[9]  S. Lowe,et al.  miR-221 overexpression contributes to liver tumorigenesis , 2009, Proceedings of the National Academy of Sciences.

[10]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  K. Ghoshal,et al.  TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.

[12]  S. Thorgeirsson,et al.  Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties , 2009, Oncogene.

[13]  M. Kurrer,et al.  A lymphotoxin-driven pathway to hepatocellular carcinoma. , 2009, Cancer cell.

[14]  J. Llovet,et al.  Lymphotoxins: new targets for hepatocellular carcinoma. , 2009, Cancer cell.

[15]  K. Ghoshal,et al.  MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib* , 2009, The Journal of Biological Chemistry.

[16]  Derek Y. Chiang,et al.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.

[17]  Shuhan Sun,et al.  Up‐regulated microRNA‐143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression , 2009, Hepatology.

[18]  S. Saad,et al.  ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration. , 2009, Biochimica et biophysica acta.

[19]  Hsien-Da Huang,et al.  MicroRNA‐122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma , 2009, Hepatology.

[20]  V. Moreau,et al.  Rho GTPases in hepatocellular carcinoma. , 2009, Biochimica et biophysica acta.

[21]  M. Karin,et al.  NF-κB signaling, liver disease and hepatoprotective agents , 2008, Oncogene.

[22]  C. Croce,et al.  MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma , 2008, Oncogene.

[23]  Anne J. Ridley,et al.  Mammalian Rho GTPases: new insights into their functions from in vivo studies , 2008, Nature Reviews Molecular Cell Biology.

[24]  Laura Pelletier,et al.  MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations , 2008, Hepatology.

[25]  Kuo-Bin Li,et al.  Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.

[26]  K. Ghoshal,et al.  MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. , 2007, Gastroenterology.

[27]  A. Elsharkawy,et al.  Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis , 2007 .

[28]  C. Croce,et al.  Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.

[29]  Frank Staib,et al.  Genetics of hepatocellular carcinoma. , 2007, World journal of gastroenterology.

[30]  V. Mazzaferro,et al.  Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma , 2007, Hepatology.

[31]  J. Tcherkezian,et al.  Current knowledge of the large RhoGAP family of proteins , 2007, Biology of the cell.

[32]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.

[33]  K. Ghoshal,et al.  Downregulation of miR‐122 in the rodent and human hepatocellular carcinomas , 2006, Journal of cellular biochemistry.

[34]  T. Okanoue,et al.  Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.

[35]  J. Bruix,et al.  Management of hepatocellular carcinoma , 2005, Hepatology.

[36]  H. Blum,et al.  Pathogenesis of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.

[37]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[38]  M. Fabbri,et al.  Epigenetics and miRNAs in human cancer. , 2010, Advances in genetics.

[39]  A. Elsharkawy,et al.  Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. , 2007, Hepatology.

[40]  V. Mazzaferro,et al.  Resection and Liver Transplantation for Hepatocellular Carcinoma , 2005, Seminars in liver disease.

[41]  G. Blandino,et al.  DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. , 2002, Molecular cell.